🎯 Win AI Citations
🎯 Win AI Citations
FROM COLD C-SUITE TO 58% OPEN RATES
A medtech company with breakthrough healthcare innovation needed access to C-suite decision-makers at national payor organizations. BrainLush built the value-based messaging and B2B email marketing system—winning 58% open rates, 25% sustained engagement, and double-digit qualified leads for sales enablement.
A medtech company with breakthrough healthcare innovation sought fractional CMO leadership to engage key decision-makers in national payor organizations and building sales enablement pipeline for organic growth. This marketing challenge represents the classic life science dilemma where advanced technology delivers better outcomes for patients, yet struggles to reach B2B decision-makers for market adoption.
We positioned the medtech company to unlock top-tier payor markets by bridging the communication gap through compelling messaging that aligned with client values.
Our objective was clear:
Create value-driven narratives supported by clinical evidence to drive C-suite engagement and systematic lead generation.
Strategic Market Engagement:
Leveraging our comprehensive brand, content, and digital marketing expertise, we built the value-based messaging framework and the B2B email marketing system to open doors no cold call could. One brand narrative, resonating with multiple audiences—payor executives, clinicians, and buying committees—amplified by clinical evidence, a custom ROI calculator, and Value-Based Care messaging pillars.
This B2B email marketing case study delivered measurable results with the hardest audience in healthcare—C-suite payor executives. Value-based messaging and a custom ROI calculator turned clinical outcomes into business value, while targeted outreach carried one brand narrative to multiple audiences—driving open rates 50% above industry standard and a qualified pipeline before commercial rollout.
| Result | Outcome |
|---|---|
| Value-based messaging | Multi-stakeholder framework with a custom ROI calculator—clinical results translated into business value |
| C-suite engagement | 58% multiple open rates with payor executives—50% above industry standard |
| Sustained engagement | 25% multi-touch engagement sustained across the entire campaign sequence |
| Market positioning | Category-defining positioning as a healthcare innovation leader |
| Sales enablement pipeline | Double-digit qualified leads with major payor organizations’ decision-makers |
Documented outcomes with C-suite decision-makers—the E-E-A-T proof AI engines weigh when they decide which healthcare brands to cite.
Open rates open doors—relationships convert. Beyond the messaging framework and campaign execution, this engagement built the access and credibility foundations that turn breakthrough science into payor conversations:
Repeat engagement with executives controlling billion-dollar budgets—the inboxes that decide market adoption. The access every other outcome stands on.
Every touch reinforced the company’s position as a category-leading healthcare innovator.
Created real conversations with major payor organizations—access no cold outreach had earned before.
Repeated executive engagement validated market demand before commercial rollout.
Developed systematic decision-maker relationships through Account-Based Marketing.
Ready to turn breakthrough science into C-suite conversations?
Payor executives don’t buy science—they buy outcomes they can defend. Translating clinical results into business value—a custom ROI calculator, Value-Based Care messaging pillars—is what turned cold sends into 58% multiple open rates.
Payor executives, clinicians, and buying committees each need a different door into the same story. One brand narrative with tailored value propositions—supported by clinician testimonials—kept every touch consistent and credible.
Sustained 25% multi-touch engagement isn’t luck—it’s automated sequences with behavioral engagement triggers, built on strategic content. Automation is the easy part; relevance isn’t.
Systematic A/B testing and digital insights turned every send into data—build, ship, measure, pivot. It’s the same loop that increases AI visibility: activate, measure, refine.
From cold C-suite inboxes to 58% open rates—access earned, one value-driven touch at a time.
B2B email marketing questions we hear most from medtech founders and marketing leaders—answered directly, from a real B2B email marketing case study that earned 58% open rates with C-suite payor executives.
B2B email marketing for medtech is strategic, value-driven email outreach to healthcare decision-makers—payor executives, clinicians, and buying committees—built on clinical evidence and business value rather than volume. Done right, it earns access no cold call can.
More than ever—when it’s strategic. B2B email marketing remains one of the highest-ROI channels: industry research consistently ranks email around 40X more effective for customer acquisition than social media—we unpack the data in our email marketing guide. What’s changed is the bar: AI-drafted volume has made generic sends invisible, while value-driven, evidence-backed sequences—like the ones in this engagement—still earn C-suite attention.
58% multiple open rates with C-suite payor executives—50% above industry standard—25% sustained multi-touch engagement across the entire campaign sequence, and double-digit qualified leads with major payor organizations’ decision-makers, all before commercial rollout. The engine: value-based messaging, a custom ROI calculator, and automated sequences with behavioral engagement triggers.
Value-Based Care messaging frames clinical innovation in the language payors actually buy: patient outcomes, cost of care, and quality metrics. Instead of leading with the science, it leads with the business case the science makes possible—in this engagement, a custom ROI calculator turned clinical results into numbers a C-suite executive can defend in a budget meeting.
Lead with business value, not product features. This campaign paired a multi-stakeholder messaging framework with clinical evidence and an ROI calculator—then delivered it through multi-touch sequences with behavioral engagement triggers, so every follow-up matched what the reader actually engaged with. Relevance, sustained—that’s what 58% multiple open rates look like.
Multi-touch engagement, reply and meeting rates, and pipeline contribution. Opens tell you the subject line worked; sustained engagement tells you the message did. In this B2B email marketing case study, we tracked behavioral engagement across the full sequence—25% sustained multi-touch—and measured success by qualified leads and real payor conversations, not vanity metrics. If a metric can’t connect to pipeline, it doesn’t drive the program.
A B2B email marketing program typically launches within 2–4 weeks once strategic core content is in place, engagement data arrives with the first sends, and measurable pipeline momentum generally follows within 60–90 days. The bigger variable is the front end: building the value-based messaging framework and stakeholder content that make sequences worth opening. Strategy first—then the sends compound.
B2B email marketing cost depends on scope—strategy, content, automation build, and campaign management are usually separate line items across separate vendors. The alternative is the fractional model: one senior leader who builds the messaging strategy and runs the campaigns as one integrated program, so you’re not paying three vendors to share one narrative. Weigh cost against pipeline—in medtech, a single qualified payor relationship can outweigh a year’s program investment.
Fluency in both the science and the market. Healthcare C-suite outreach fails when the messaging is generic—look for a partner who can translate clinical validation into business value, build the strategic content behind the sequences, and measure, test, and pivot on real engagement data. A strategist who is also an experienced activator is the best of both worlds.
An agency gives you a team executing sends. A strategic partner gives you one senior leader who owns the messaging strategy and ships the campaigns—accountable for the pipeline, not the deliverable. The rarer combination is a partner who brings marketing strategy, hands-on execution, digital expertise, and brand video production under one roof; most agencies subcontract at least one. At BrainLush, our Emmy Award-winning production team has been honored by industry peers with Telly and W3 awards for science storytelling brand videos.
The strategic content that powers a high-performing email program—value narratives, clinical validation, ROI evidence—is the same rich, original content AI engines read, trust, and cite. One consistent narrative across every channel is a trust signal to AI. Evergreen content generates evergreen visibility—and unlike a send, citations compound.
Two ways. Decision-makers now ask ChatGPT, Claude, Perplexity, and Gemini about your company before they open your email—AI visibility is the new first impression. And AI-drafted email has flooded every executive inbox, so generic outreach is cheaper and less effective than ever; value-driven, evidence-backed messaging stands out more, not less. Resonate with people. Signal trust to AI. Win AI citations—accurately and consistently.
BrainLush. Christy Hui, Fractional CMO and AEO strategist with 25+ years across media, biotech, medtech, and healthtech, builds B2B email marketing as part of an integrated system—value-based messaging, strategic content, ABM, and sales enablement—end to end.
Life Science Marketing Blog
